Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kenvue Inc. Common Stock (KVUE) vs Weyerhaeuser Company Common Stock (WY) Price & Performance

Kenvue Inc. Common StockTrade
Weyerhaeuser Company Common StockTrade

Price performance (Past 24H)

Key statistics

Kenvue Inc. Common Stock vs Weyerhaeuser Company Common Stock — how do they compare? Kenvue Inc. Common Stock trades at $18.2 (market cap $34.59B), while Weyerhaeuser Company Common Stock trades at $19.04 (market cap $13.62B). The key difference: Kenvue Inc. Common Stock is far larger — about 2.5× Weyerhaeuser Company Common Stock's market cap, and Kenvue Inc. Common Stock pays the higher dividend (4.66%). Which is the better fit depends on your goals.

KVUEWY
Market Cap
$34.59B$13.62B
Volume
27,608,4028,637,043
Sector
Consumer StaplesReal Estate
52-Week High
$19.83$27.10
52-Week Low
$14.11$18.47
Typical Hold Time
1 Days—
Enterprise Value
$42.10B$18.54B
Dividend Yield
4.66%4.44%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Kenvue Inc. Common Stock

Kenvue (KVUE) trades at $17.76, down 0.39% on the day, with a bearish technical signal and neutral oscillators. The company reported revenue of $15.12B in 2025, with a net income margin of 10.76% and a P/E ratio of 20.89. Recent news highlights conditional EU approval for Kimberly-Clark's $40B acquisition of Kenvue, potentially impacting future operations and shareholder returns.

The outlook is mixed, with strong profitability and consistent dividend payments offering stability, but the pending acquisition introduces uncertainty. Risks include integration challenges and market volatility. Analyst consensus is a Hold with a $19.50 price target, suggesting limited near-term upside from current levels.

Weyerhaeuser Company Common Stock

Weyerhaeuser (WY) trades at $18.97, up 0.16% with neutral technical signals. The stock shows strong earnings momentum, beating estimates for three consecutive quarters, while fundamentals reveal modest profitability with 6.89% net margin and 4.97% ROE. Recent news highlights institutional accumulation and upcoming Q3 earnings on October 29. The company maintains stable revenue at $6.9B but faces cash flow challenges with negative net cash flow of $203M in 2025.

Weyerhaeuser presents a mixed outlook with analyst consensus favoring bullish sentiment (52% buy ratings) and a $29.33 price target suggesting 55% upside. However, risks include weak dividend coverage, high leverage at 5x, and sensitivity to interest rates and housing market cycles. The stock's current proximity to 52-week lows offers potential value but requires careful monitoring of lumber demand recovery and Q3 earnings results.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Kenvue Inc. Common Stock

Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.

Read more on KVUE →

About Weyerhaeuser Company Common Stock

Weyerhaeuser Company is a timberland-focused real estate investment trust (REIT) that owns and manages more than 10 million acres of timberland in US, in addition to timberlands under long-term license in Canada. The company also manufactures wood products, including lumber, oriented strand board, and engineered wood.

Read more on WY →